Literature DB >> 32207998

National Health Expenditure Projections, 2019-28: Expected Rebound In Prices Drives Rising Spending Growth.

Sean P Keehan1, Gigi A Cuckler2, John A Poisal3, Andrea M Sisko4, Sheila D Smith5, Andrew J Madison6, Kathryn E Rennie7, Jacqueline A Fiore8, James C Hardesty9.   

Abstract

National health expenditures are projected to grow at an average annual rate of 5.4 percent for 2019-28 and to represent 19.7 percent of gross domestic product by the end of the period. Price growth for medical goods and services is projected to accelerate, averaging 2.4 percent per year for 2019-28, which partly reflects faster expected growth in health-sector wages. Among all major payers, Medicare is expected to experience the fastest spending growth (7.6 percent per year), largely as a result of having the highest projected enrollment growth. The insured share of the population is expected to fall from 90.6 percent in 2018 to 89.4 percent by 2028.

Keywords:  Cost growth; Costs and spending; Health policy; Medicaid; Medicaid services; Medicare; National health expenditures; Prescription drugs; Private health insurance; Wellness

Mesh:

Year:  2020        PMID: 32207998     DOI: 10.1377/hlthaff.2020.00094

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  20 in total

1.  Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use.

Authors:  Taryn A G Quinlan; Andrew W Roberts; Joseph W Frank; Melanie D Whittington
Journal:  Health Serv Res       Date:  2021-09-12       Impact factor: 3.402

2.  Estimation of Potential Savings Associated With Switching Medication Formulation.

Authors:  Sunita M Desai; Jiejie Wang; Uttara M Ananthakrishnan; Ishita Ghai; Ateev Mehrotra; Hemant K Bhargava
Journal:  JAMA Health Forum       Date:  2022-02-04

Review 3.  The Promise of Digital Health: Then, Now, and the Future.

Authors:  Amy Abernethy; Laura Adams; Meredith Barrett; Christine Bechtel; Patricia Brennan; Atul Butte; Judith Faulkner; Elaine Fontaine; Stephen Friedhoff; John Halamka; Michael Howell; Kevin Johnson; Peter Long; Deven McGraw; Redonda Miller; Peter Lee; Jonathan Perlin; Donald Rucker; Lew Sandy; Lucia Savage; Lisa Stump; Paul Tang; Eric Topol; Reed Tuckson; Kristen Valdes
Journal:  NAM Perspect       Date:  2022-06-27

4.  Temporal Trends for Patients Hospitalized With Atrial Fibrillation in the United States: An Analysis From the National Inpatient Sample (NIS) Database 2011-2018.

Authors:  Brian Foster; Adnan Liaqat; Awais Farooq; Sagar Kulkarni; Saikiran Mandyam; Pooja Patak; Mo Zaman; Paramjit Kaur; Sebastian Tosto; Arthur Kendig
Journal:  Cureus       Date:  2022-06-06

5.  Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis.

Authors:  Sean Day; Veeraj Shah; Sari Kaganoff; Shannon Powelson; Simon C Mathews
Journal:  J Med Internet Res       Date:  2022-06-20       Impact factor: 7.076

6.  Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30-day readmissions.

Authors:  Sara Yang; William Adams; Carol Bier-Laning
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-05-02

7.  Smart moves for an aging population.

Authors:  Samuel R Josephsen; Roschelle L Fritz
Journal:  J Am Geriatr Soc       Date:  2021-03-13       Impact factor: 7.538

Review 8.  Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer.

Authors:  Mina Wang; Feiyu Xie; Jiaran Lin; Yihan Zhao; Qian Zhang; Zehuan Liao; Peng Wei
Journal:  Front Med (Lausanne)       Date:  2021-03-18

9.  Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey.

Authors:  Riyad Kherallah; Mahmoud Al Rifai; Ishan Kamat; Chayakrit Krittanawong; Dhruv Mahtta; Michelle T Lee; Jing Liu; Khurram Nasir; Javier Valero-Elizondo; Jaideep Patel; Mouaz H Al-Mallah; Laura A Petersen; Salim S Virani
Journal:  Prev Med       Date:  2021-07-07       Impact factor: 4.637

10.  Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures.

Authors:  Rebecca L Tisdale; Iris Ma; Daniel Vail; Jay Bhattacharya; Jeremy D Goldhaber-Fiebert; Paul A Heidenreich; Alexander T Sandhu
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.